Psychiatry and Neurology, Neurology · East Setauket, NY
NPI
1033440896
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
179 Belle Mead Rd
East Setauket, NY, 11733
Phone (631) 444-2599
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
727 services
Medicare patients, 2024
223
Average age 65
Drug cost, 2024
$4.2M
2,663 prescriptions
Company payments, 2025
$87K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patricia M Melville was code 99214 (office e&m - established), 173 times for 139 patients. In total Patricia M Melville billed 727 services in 27 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 173 | 139 | $85.49 | $15K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 73 | 36 | $0.51 | $37.14 |
| 96365 Intravenous Infusion, Hydration | Office | 53 | 24 | $50.99 | $2,703 |
| 99205 Office E&M - New | Office | 33 | 33 | $162.00 | $5,346 |
| 96413 Chemotherapy Administration | Office | 23 | 14 | $99.84 | $2,296 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 17 | 11 | $0.39 | $6.59 |
| 99213 Office E&M - Established | Office | 15 | 11 | $68.41 | $1,026 |
By year: 2022 $20K for 199 services; 2023 $49K for 598 services; 2024 $47K for 727 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patricia M Melville prescribed most often to Medicare patients was Levetiracetam, with 159 prescriptions and refills. In total Patricia M Melville wrote 2,663 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 159 | 245 | 34 | $6,748 |
| Lacosamide Generic | 117 | 140 | 22 | $19K |
| Gabapentin Generic | 99 | 196 | 32 | $1,716 |
| Lamictal Lamotrigine | 92 | 108 | 13 | $145K |
| Clobazam Generic | 92 | 130 | 21 | $28K |
| Carbamazepine Er Carbamazepine | 72 | 86 | 11 | $9,780 |
| Xcopri Cenobamate | 72 | 72 | Under 11 | $104K |
| Baclofen Generic | 71 | 161 | 22 | $2,319 |
| Briviact Brivaracetam | 65 | 67 | Under 11 | $108K |
| Divalproex Sodium Er Divalproex Sodium | 61 | 77 | Under 11 | $8,870 |
| Qulipta Atogepant | 61 | 63 | 13 | $65K |
| Clonazepam Generic | 57 | 57 | Under 11 | $723 |
| Zonisamide Generic | 57 | 93 | 13 | $2,780 |
| Nurtec Odt Rimegepant Sulfate | 55 | 57 | 20 | $74K |
| Tizanidine Hcl Generic | 47 | 125 | 14 | $1,599 |
Brand drugs: 938 claims; generic drugs: 1,700 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patricia M Melville $87K ($87K in general payments such as food, travel and fees) from 13 companies. The largest payer was TG Therapeutics, Inc. with $31K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 35 | $31K |
| Genentech USA, Inc. ROG.SW | 34 | $25K |
| Amgen Inc. AMGN | 29 | $21K |
| Novartis Pharmaceuticals Corporation NVS | 9 | $5,844 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $3,161 |
| EMD Serono, Inc. MRK.DE | 4 | $422 |
| Abbvie Inc. ABBV | 12 | $193 |
| Biogen, Inc. BIIB | 2 | $180 |
| Argenx US, Inc. ARGX | 1 | $125 |
| Lundbeck LLC | 3 | $62.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.